Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study
Shinichi Imafuku, Yasumasa Kanai, Kenta Murotani, et al.
Journal of Dermatological Science (2021) Vol. 101, Iss. 3, pp. 185-193
Open Access | Times Cited: 24

Showing 24 citing articles:

Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)
Matthias Augustin, Rachel Sommer, E. Daudén, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e060536-e060536
Open Access | Times Cited: 16
Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study
Yiran Chen, Lei Wei, Yu Song, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 11
Targeted therapy for immune mediated skin diseases. What should a dermatologist know?
Edinson López, Raúl Cabrera, Cristóbal Lecaros
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 4, pp. 546-567
Open Access | Times Cited: 3
Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity
Masaru Honma, Hiroyoshi Nozaki
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3199-3199
Open Access | Times Cited: 19
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study
Chika Ohata, Yasumasa Kanai, Kenta Murotani, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1039-1052
Open Access | Times Cited: 8
A Promising Approach of Dermal Targeting of Antipsoriatic Drugs via Engineered Nanocarriers Drug Delivery Systems for Tackling Psoriasis
Devika Tripathi, Mansi Srivastava, Krislay Rathour, et al.
Drug Metabolism and Bioanalysis Letters (2023) Vol. 16, Iss. 2, pp. 89-104
Closed Access | Times Cited: 7
Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study
Shinichi Imafuku, Chika Ohata, Yukari Okubo, et al.
Journal of Dermatological Science (2022) Vol. 105, Iss. 3, pp. 176-184
Closed Access | Times Cited: 12
Brodalumab for Plaque Psoriasis: A Canadian Real-World Experience at 2-Years Post-Launch
V. Gaudet, Belinda Yap, Shazia Hassan, et al.
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 3, pp. 226-235
Closed Access | Times Cited: 5
Work productivity in real‐life employed patients with plaque psoriasis: Results from the ProLOGUE study
Hidehisa Saeki, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 49, Iss. 10, pp. 970-978
Open Access | Times Cited: 8
Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study
Takuya Miyagi, Yasumasa Kanai, Kenta Murotani, et al.
JAAD International (2022) Vol. 8, pp. 146-153
Open Access | Times Cited: 7
Impact of residual skin lesions and previous biologic treatment failure on patient‐reported outcomes in patients with psoriasis receiving biologic treatment
Won Ji Song, Hyun‐Sun Yoon
The Journal of Dermatology (2024) Vol. 51, Iss. 6, pp. 772-778
Open Access | Times Cited: 1
[Artículo traducido] Calidad de vida y región corporal afectada por la psoriasis: una revisión sistemática
Karina Nabieva, Ronald Vender
Actas Dermo-Sifiliográficas (2022) Vol. 114, Iss. 1, pp. T33-T38
Open Access | Times Cited: 6
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
Suganthy Robinson, Min Moon Tang, Tey Kwee Eng, et al.
Drugs - Real World Outcomes (2023) Vol. 10, Iss. 2, pp. 291-298
Open Access | Times Cited: 3
Itching and skin pain in real-life patients with plaque psoriasis: Baseline analysis of the ProLOGUE study
Masaru Honma, Yasumasa Kanai, Kenta Murotani, et al.
Journal of Dermatological Science (2022) Vol. 105, Iss. 3, pp. 189-191
Open Access | Times Cited: 3
Real‐world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch)
Jolijn C. Bethlem, Jenny A. H. M. Janssens, Milan Tjioe
JEADV Clinical Practice (2023) Vol. 2, Iss. 3, pp. 510-517
Open Access | Times Cited: 1
Health Related Quality of Life in Patients with Psoriasis
Jin Ho Kim, Hyo Jin Yoon, Kyung Duck Park
Daehan geonseon hakoeji (Online) (2023) Vol. 20, Iss. 2, pp. 51-58
Open Access | Times Cited: 1
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Philip J. Mease, Andrew Blauvelt, Adam Šíma, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 10, pp. 2805-2825
Open Access
Terapia direcionada para doenças imunomediadas da pele. O que o dermatologista deve saber?
Edinson López, Raúl Cabrera, Cristóbal Lecaros
(2024) Vol. 99, Iss. 4, pp. 546-567
Open Access
Difference in health‐related quality of life between anxiety and depressive symptoms in Japanese patients with plaque psoriasis: the ProLOGUE study
Chika Ohata, Yuko Kanai, Kenta Murotani, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 1
Open Access | Times Cited: 3
Treatment with brodalumab is not associated with improved sleep problems in real‐life patients with plaque psoriasis: Results of the ProLOGUE study
Yoko Mizutani, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 3, pp. 319-326
Open Access | Times Cited: 2
Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study
Masaru Honma, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 4, pp. 453-461
Closed Access | Times Cited: 2
Research Progress on the Correlation between Psoriasis and Glucose and Lipid Metabolism
梦 刘
Advances in Clinical Medicine (2022) Vol. 12, Iss. 03, pp. 2010-2016
Closed Access | Times Cited: 1
The Influence of Treatment Modalities on the Quality of Life of Psoriasis Patients
Ardea Milidrag, Teodora Safiye, Medo Gutić, et al.
Iranian Journal of Public Health (2023)
Open Access
Properties and Use of the Dermatology Life Quality Index in Patients with Psoriasis
Д. А. Андреев, Н Н Камынина
City Healthcare (2023) Vol. 4, Iss. 4, pp. 122-134
Open Access
Page 1

Scroll to top